November 13, 2023
1 min watch
Save
VIDEO: Progressive pediatric myopia treatment at the tail end of phase 3 clinical trial
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients.
The treatment “is at the tail end of its phase 3 clinical trials,” and the company anticipates unmasking the data in the second quarter of 2024, he said.
Published by:
Sources/Disclosures
Collapse
Source:
Ruth N. Anterior segment showcase: Sydnexis. Presented at: Eyecelerator@AAO; Nov. 2, 2023; San Francisco.
Disclosures:
Ruth reports being the CEO of Sydnexis.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.